Please assess the completion status of the following clinical trial:

Trial Title: Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients With Multiple Sclerosis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients willing to sign informed consent and capable of understanding the features of this clinical trial.~* Willing to keep a weekly diary and undergo observation for 12 months~* Non-pregnant patients 18-55 years of age with MS according to the revised McDonald criteria and meeting the Poser criteria for clinically defined MS.~* EDSS scores of 2·0 to 5·5 points assessed at least 3 months after the last acute attack of MS.~* Must have proof of health insurance in country of residence.~Exclusion Criteria:~* Patients with evidence of active proliferative retinopathy.~* Patients with poorly controlled diabetes mellitus (glycated hemoglobin: HbA1C \> 8.5%).~* Patients with renal insufficiency (Creatinine\> 2.5) or failure.~* Infection as evidenced by white blood cell (WBC) count of \>15,000 k/cumm and/or temperature \> 38 Celsius.~* History of organ transplant.~* History of previous or active malignancy, except for localised cutaneous basal or squamous cell carcinoma or carcinoma in situ of the cervix~* Exercise limiting angina ( Canadian Cardiovascular Society Class 3~* Congestive heart failure (New York Heart Association class 3~* Unstable angina~* Acute ST elevation myocardial infarction (MI) within 1month~* Transient ischemic heart attack or stroke within 1 month~* Severe valvular heart disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- Umbilical cord mesenchymal stem cells (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).